BKYI BIO KEY INTERNATIONAL INC
Services-Prepackaged Software · Nasdaq · SEC CIK 1019034 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.0%
TTM net income YoY-40.1%
TTM EPS YoY—
Revenue 3-yr CAGR-4.8%
Net income 3-yr CAGR—
Margins
Gross margin84.4%
Operating margin-86.2%
Net margin-89.8%
FCF margin-67.5%
EBITDA margin-85.3%
Returns
ROE-94.7%
ROA-62.8%
ROIC (approx.)-108.5%
Asset turnover0.70x
Leverage & solvency
Liabilities / assets26.0%
Debt / equity0.00x
Current ratio2.47x
Interest coverage-129.12x
Cash quality & payout
Operating cash flow / net income0.75x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $5.94M | $6.93M | $7.75M | $7.02M | $5.11M |
| Cost of revenue | $1.37M | $1.29M | $6.32M | $2.44M | $1.67M |
| Gross profit | $4.56M | $5.64M | $1.43M | $4.58M | $3.44M |
| R&D expense | $2.61M | $2.51M | $2.39M | $3.25M | $2.36M |
| SG&A expense | $6.28M | $7.14M | $7.86M | $9.36M | $6.03M |
| Operating income | -$6.83M | -$4.01M | -$8.83M | -$9.92M | -$4.94M |
| Interest expense | $60,793 | $175,755 | $218,270 | $10,462 | $18,000 |
| Pretax income | -$7.14M | -$4.32M | -$8.66M | -$11.93M | $0 |
| Income tax | $16,500 | -$22,998 | -$134,014 | -$20,434 | $0 |
| Net income | -$7.16M | -$4.30M | -$8.52M | -$11.91M | -$5.07M |
| EBITDA | -$6.74M | -$3.92M | -$8.75M | -$9.88M | -$4.89M |
| EPS (basic) | -10.77 | -20.88 | -15.21 | -27.26 | -0.65 |
| EPS (diluted) | — | — | — | — | -0.65 |
| Weighted avg. shares (diluted) | — | — | — | — | 7.79M |
| Balance sheet | |||||
| Cash & equivalents | $2.69M | $437,604 | $511,400 | $2.64M | $7.75M |
| Receivables | $1.22M | $718,229 | $1.20M | $1.52M | $970,626 |
| Inventory | $370,879 | $378,307 | $445,740 | $4.43M | $4.94M |
| Current assets | $4.54M | $1.89M | $2.62M | $8.98M | $14.01M |
| PP&E, net | $67,751 | $140,198 | $220,177 | $107,413 | $69,168 |
| Goodwill | — | — | — | $0 | $1.26M |
| Intangibles | $830,357 | $1.10M | $1.41M | $1.76M | $1.30M |
| Total assets | $8.30M | $8.62M | $4.52M | $11.34M | $17.77M |
| Current liabilities | $3.10M | $4.55M | $3.21M | $5.46M | $2.00M |
| Short-term debt | — | — | $138,730 | $120,000 | $0 |
| Long-term debt | — | $44,762 | $188,787 | $326,767 | $0 |
| Total debt | — | $44,762 | $327,517 | $446,767 | $0 |
| Total liabilities | $3.20M | $4.84M | $3.45M | $6.04M | $2.15M |
| Shareholders' equity | $5.11M | $3.77M | $1.06M | $5.30M | $15.62M |
| Net debt | — | -$392,842 | -$183,883 | -$2.19M | -$7.75M |
| Shares outstanding | 1.09M | 371,696 | 1.03M | 552,739 | 7.85M |
| Cash flow statement | |||||
| Operating cash flow | -$4.67M | -$2.91M | -$3.79M | -$6.23M | -$8.98M |
| Capital expenditure | $12,012 | $13,047 | $1,000 | $82,040 | $42,024 |
| Free cash flow | -$4.68M | -$2.93M | -$3.79M | -$6.31M | -$9.02M |
| Investing cash flow | -$12,012 | -$13,047 | -$1,000 | -$696,618 | -$42,024 |
| Financing cash flow | $6.91M | $2.83M | $1.43M | $1.90M | -$218,598 |
| Depreciation & amortization | $84,458 | $93,026 | $75,136 | $43,794 | $54,649 |
| Stock-based compensation | $166,575 | $243,250 | $265,732 | $387,907 | $314,715 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.